Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 21, 2001

View Archived Issues

Amrad product pipeline update

2000 highlights reported for Cell Therapeutics

Shire reviews Q4 and year-end 2000 developments

Two studies demonstrate efficacy of ziprasidone in patients with schizoaffective disorder

Demegen's antimicrobial peptide shows efficacy against herpesviruses and Chlamydia

Antiinfective properties of Pharming's hLF reported; AM-Pharma licenses Pharming peptide technology

Cellegy accelerates filing for Anogesic in Canada

Ribozyme and Chiron begin phase II trial with Angiozyme for breast cancer

Botulinum toxin type A preparation proves safe and effective in axillary hyperhidrosis

Update on phase II trials with Nobex's oral insulin reported

Promising toxicity and pharmacokinetic findings emerge from phase Ia trial of doranidazole

Orally active small-molecule GnRH antagonists presented by Neurocrine Biosciences

Review of Aslera NDA rescheduled for April

Pentasaccharide registration submission and other important events at Sanofi-Synthelabo

Access reports positive phase III data for OraDisc canker sore treatment

AtheroGenics moves second product into clinical development

Phase II trials of SMART 1D10 antibody begin in non-Hodgkin's lymphoma

BASB113 polynucleotides and polypeptides for use as vaccines

Chlamydia polypeptide and use in DNA vaccines

Antibacterial quinolinecarboxylic acid derivatives in development at Wakunaga

Taisho presents new VEGF receptor antagonists with antiangiogenic/antitumor activity

Hybrigenics and Servier to identify new targets for anticancer drugs

New treatments for osteoporosis with an indole structure

Merck reports compounds with the ability to inhibit cytokine production or activity

Recent patent covers metabotropic glutamate receptor antagonists selective for group II/III

Sigma receptor ligands and use as antipsychotics, etc., reported by Sanofi-Synthelabo

Dihydrobenzodiazepines and use in dyslipidemias, diabetes, etc.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...